Marci Kowalewski
Physician Assistant · Waymart, PANPI 1477658235
Payments from drug & device makers
Across 725 payments — averaging $16.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$2K
- Novo Nordisk$2K
- AstraZeneca$1K
- Boehringer Ingelheim$1K
- GSK$928
- Lilly USA, LLC$863
- plus $5K from 32 others
What the payments were for
- Food & beverage$12,12999%
- Education$1691%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 82 | $1,749 |
| Novo Nordisk | 103 | $1,529 |
| AstraZeneca | 68 | $1,159 |
| Boehringer Ingelheim | 55 | $1,035 |
| GSK | 52 | $928 |
| Lilly USA, LLC | 62 | $863 |
| AbbVie | 52 | $755 |
| Dexcom, Inc. | 30 | $522 |
| Lundbeck LLC | 24 | $423 |
| Daiichi Sankyo Inc. | 25 | $310 |
| Abbott | 17 | $290 |
| Otsuka America Pharmaceutical, Inc. | 11 | $251 |
| Nestle Healthcare Nutrition Inc. | 14 | $245 |
| Esperion Therapeutics, Inc. | 11 | $203 |
| Novartis | 11 | $200 |
| Kowa Pharmaceuticals America, Inc. | 13 | $178 |
| Merck | 10 | $175 |
| Astellas Pharma US Inc | 6 | $170 |
| Exact Sciences | 9 | $165 |
| E.r. Squibb & Sons, L.L.C. | 10 | $138 |
| Pfizer | 8 | $130 |
| Sanofi-aventis U.S. LLC | 8 | $126 |
| Aimmune Therapeutics, Inc. | 6 | $118 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $95 |
| Eisai Inc. | 5 | $69 |
| Kaleo, Inc. | 4 | $65 |
| Johnson & Johnson | 4 | $60 |
| Myriad Women's Health, Inc. | 1 | $50 |
| Impel Pharmaceuticals Inc. | 2 | $45 |
| Teleflex LLC | 2 | $37 |
| Bayer | 2 | $33 |
| Amarin Pharma, Inc. | 2 | $32 |
| Axsome Therapeutics, Inc. | 2 | $31 |
| Sumitomo Pharma America, Inc. | 2 | $30 |
| Axonics, Inc. | 2 | $29 |
| Arbor Pharmaceuticals, Inc. | 2 | $28 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| Biohaven Pharmaceuticals, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,297 in reported general payments places this provider in the 95th percentile of 6,643 physician assistant providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 107 | $81,114 |
| JardianceEmpagliflozin | 65 | $55,009 |
| OzempicSemaglutide | 37 | $46,416 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 32 | $36,003 |
| TrulicityDulaglutide | 33 | $34,403 |
| Repatha SureclickEvolocumab | 52 | $32,432 |
| MounjaroTirzepatide | 31 | $31,506 |
| XareltoRivaroxaban | 52 | $27,622 |
| WegovySemaglutide | 18 | $23,912 |
| RybelsusSemaglutide | 15 | $16,029 |
| FarxigaDapagliflozin Propanediol | 20 | $10,695 |
| Breo ElliptaFluticasone/Vilanterol | 25 | $9,942 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 14 | $7,516 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 20 | $5,831 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 30 | $5,059 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Wegovy, Rybelsus | $1,529 | $86,35770 claims |
| PfizerEliquis | $130 | $81,114107 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $863 | $65,90964 claims |
| Boehringer IngelheimJardiance, Synjardy Xr | $1,035 | $62,52579 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta | $928 | $49,55269 claims |
| Johnson & JohnsonXarelto | $60 | $27,62252 claims |
| AstraZenecaFarxiga | $1,159 | $10,69520 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,643 physician assistant providers in Pennsylvania.
Other physician assistant in Waymart
- Erin CrownState College$1.5M
- Tricia BootsCranberry Twp$313K
- Melissa FerrariPhiladelphia$223K
- Jason OberdickWexford$206K
- Justine RobertsMurrysville$173K
- Allison BoydErie$163K
- Joshua TrbovichWashington$144K
- Daniel TelegaErie$124K
- Alvin KingcadePhiladelphia$101K
- Jeffrey CameronWashington$89K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.